Superficial phlebitis and phase 3.5 trials.
Goldman
Lee
L
Ginsberg
Jeffrey
J
D000925:Anticoagulants / Q000191:economics / Q000627:therapeutic use*; D017326:Clinical Trials, Phase III as Topic; D003362:Cost-Benefit Analysis; D000077425:Fondaparinux; D006801:Humans; D056687:Off-Label Use; D011134:Polysaccharides / Q000191:economics / Q000627:therapeutic use*; D011655:Pulmonary Embolism / Q000517:prevention & control; D014481:United States; D014486:United States Food and Drug Administration; D020246:Venous Thrombosis / Q000188:drug therapy*
D000925:Anticoagulants; D011134:Polysaccharides; D000077425:Fondaparinux